Pathology of peripheral T-cell lymphomas: where do we stand? - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Seminars in Hematology Year : 2014

Pathology of peripheral T-cell lymphomas: where do we stand?


Peripheral T-cell lymphomas (PTCLs) are heterogeneous and uncommon malignancies characterized by a usually aggressive clinical course. The current World Health Organization (WHO) classification delineates many entities grouped according to the clinical presentation as predominantly leukemic, cutaneous, extranodal, or nodal diseases. Yet, few genetic lesions serve as entity-defining markers. Using high-throughput methods, new recurrent genetic and molecular alterations are being discovered that are expected to refine the current classification and serve as diagnostic genetic markers and targets for novel therapies. There is increasing evidence that certain cellular subsets, in particular follicular helper T cells and gamma delta T cells, represent important defining markers and/or determinants of the biology of certain entities; nevertheless, the cellular derivation of many PTCL entities remains poorly characterized and there is evidence of plasticity in terms of cellular derivation (alpha-beta, gamma-delta, natural killer [NK]) especially in several extranodal entities with a cytotoxic profile. While most clonal NK/T-cell proliferations are in general highly malignant, some more indolent forms of NK or T-cell lympho-proliferations are being identified.
Embargoed file
Embargoed file
Visibility date is undetermined

Dates and versions

inserm-00957335 , version 1 (10-03-2014)



Philippe Gaulard, Laurence de Leval. Pathology of peripheral T-cell lymphomas: where do we stand?. Seminars in Hematology, 2014, 51 (1), pp.5-16. ⟨10.1053/j.seminhematol.2013.11.003⟩. ⟨inserm-00957335⟩


83 View
1 Download



Gmail Mastodon Facebook X LinkedIn More